SCHEMBL30830949

SCHEMBL30830949

CC(C)(C)OC(=O)N1CCC2(CC1)CCN(c1ccc(OC3CCC(=O)NC3=O)cc1)CC2

nearest known ligand 0.64

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ DDB1 Q16531 13/20 0.64
▸ CRBN Q96SW2 13/20 0.64
▸ GPR119 Q8TDV5 7/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29744797 0.92 DDB1 (0.74) DDB1CRBNGPR119
SCHEMBL20595415 0.92 DDB1 (0.74) DDB1CRBNGPR119
SCHEMBL21903077 0.92 DDB1 (0.74) DDB1CRBNGPR119
SCHEMBL29947073 0.89 DDB1 (0.72) DDB1CRBNGPR119
Hydrochloric Acid SCHEMBL29947007 0.87 DDB1 (0.67) DDB1CRBNGPR119
SCHEMBL31726711 0.84 DDB1 (0.60) DDB1CRBNGPR119
SCHEMBL29680886 0.84 DDB1 (0.60) DDB1CRBNGPR119
SCHEMBL23301516 0.82 DDB1 (0.62) DDB1CRBNGPR119
SCHEMBL24125822 0.82 DDB1 (0.62) DDB1CRBNGPR119
SCHEMBL24125697 0.82 DDB1 (0.62) DDB1CRBNGPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 — — EP disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 — — WO disclosed
Send feedback